M&As this week: LDC, JSS Medical Research

9 June 2016 (Last Updated June 9th, 2016 18:30)

LDC (Managers) Limited has divested Synexus Clinical Research to Jaguar Holdings Company, a holdings company of Pharmaceutical product Development (PPD).

LDC (Managers) Limited has divested Synexus Clinical Research to Jaguar Holdings Company, a holdings company of Pharmaceutical product Development (PPD).

The $258.33m transaction generates 2.3x money multiple for LDC and enables Synexus to achieve a substantial growth in the market.

JSS Medical Research plans to establish its presence and provide its services to clients in Europe and surrounding regions by acquiring Bonne Sante, a marketing company specialised in promotion of gastroenterology products.

The acquisition enables both companies to improve their operational efficiencies and international business development and expand their client services.